Literature DB >> 12021318

Distinct requirement for two stages of protein-primed initiation of reverse transcription in hepadnaviruses.

Xingtai Wang1, Jianming Hu.   

Abstract

Reverse transcription in hepadnaviruses is primed by the viral reverse transcriptase (RT) (protein priming) and requires the specific interaction between the RT and a viral RNA signal termed epsilon, which bears the specific template sequence for protein priming. The product of protein priming is a short oligodeoxynucleotide which represents the 5' end of the viral minus-strand DNA and is covalently attached to the RT. We have now identified truncated RT variants from the duck hepatitis B virus that were fully active in the initial step of protein priming, i.e., the covalent attachment of the first nucleotide to the protein (RT deoxynucleotidylation), but defective in any subsequent DNA polymerization. A short sequence in the RT domain was localized that was dispensable for RT deoxynucleotidylation but essential for the subsequent DNA polymerization. These results have thus revealed two distinct stages of protein priming, i.e., the initial attachment of the first nucleotide to the RT (RT deoxynucleotidylation or initiation of protein priming) and the subsequent DNA synthesis (polymerization) to complete protein priming, with the second step entailing additional RT sequences. Two models are proposed to explain the observed differential sequence requirement for the two distinct stages of the protein priming reaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021318      PMCID: PMC136195          DOI: 10.1128/jvi.76.12.5857-5865.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins.

Authors:  Jianming Hu; David Toft; Dana Anselmo; Xingtai Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  The (I/Y)XGG motif of adenovirus DNA polymerase affects template DNA binding and the transition from initiation to elongation.

Authors:  A B Brenkman; M R Heideman; V Truniger; M Salas; P C van der Vliet
Journal:  J Biol Chem       Date:  2001-06-04       Impact factor: 5.157

Review 3.  Hepatitis B virus biology.

Authors:  C Seeger; W S Mason
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

4.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

5.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.

Authors:  X Lin; Z H Yuan; L Wu; J P Ding; Y M Wen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

Authors:  K Das; X Xiong; H Yang; C E Westland; C S Gibbs; S G Sarafianos; E Arnold
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate.

Authors:  J Summers; W S Mason
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

9.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

10.  p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.

Authors:  N Grammatikakis; J H Lin; A Grammatikakis; P N Tsichlis; B H Cochran
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

View more
  14 in total

1.  Heat shock protein 90-independent activation of truncated hepadnavirus reverse transcriptase.

Authors:  Xingtai Wang; Xiaofeng Qian; Hwai-Chen Guo; Jianming Hu
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  In vitro epsilon RNA-dependent protein priming activity of human hepatitis B virus polymerase.

Authors:  Scott A Jones; Rajeev Boregowda; Thomas E Spratt; Jianming Hu
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Cryptic protein priming sites in two different domains of duck hepatitis B virus reverse transcriptase for initiating DNA synthesis in vitro.

Authors:  Rajeev K Boregowda; Li Lin; Qin Zhu; Fang Tian; Jianming Hu
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Protein-primed terminal transferase activity of hepatitis B virus polymerase.

Authors:  Scott A Jones; Jianming Hu
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine.

Authors:  Scott A Jones; Eisuke Murakami; William Delaney; Phillip Furman; Jianming Hu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

6.  Functional and structural dynamics of hepadnavirus reverse transcriptase during protein-primed initiation of reverse transcription: effects of metal ions.

Authors:  Li Lin; Fen Wan; Jianming Hu
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

7.  Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.

Authors:  Kathie-Anne Walters; Graham A Tipples; Marchelle I Allen; Lynn D Condreay; William R Addison; Lorne Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 8.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

9.  Hepatitis B virus reverse transcriptase and epsilon RNA sequences required for specific interaction in vitro.

Authors:  Jianming Hu; Morgan Boyer
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Self-guanylylation of birnavirus VP1 does not require an intact polymerase activity site.

Authors:  Junhua Pan; Li Lin; Yizhi Jane Tao
Journal:  Virology       Date:  2009-10-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.